Trial of eRapa to Prevent Progression in Familial Adenomatous Polyposis Patients Under Active Surveillance
收藏NIAID Data Ecosystem2026-03-12 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2327106
下载链接
链接失效反馈官方服务：
资源简介：
Patients with Familial Adenomatous Polyposis (FAP) who are undergoing endoscopic surveillance will be given Encapsulated Rapamycin (eRapa) at one of three escalating doses/schedules for 12 months with the aim of reducing polyp burden.
创建时间：
2021-01-15
